Epilepsy and neuropsychological comorbidities

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 3, 2013, Pages 682-696

  Rudzinski, Leslie A ^a   Meador, Kimford J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AGGRESSION; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ATTENTION; BEDTIME DOSAGE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; EXECUTIVE FUNCTION; FATIGUE; HIGH RISK PATIENT; HUMAN; HYPERACTIVITY; INTELLIGENCE QUOTIENT; IRRITABILITY; LANGUAGE DISABILITY; LEARNING DISORDER; MAJOR DEPRESSION; MEMORY; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL DISEASE; MENTAL INSTABILITY; MOOD DISORDER; NERVOUSNESS; PREVALENCE; PSYCHOLOGICAL WELL BEING; PSYCHOMOTOR ACTIVITY; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; STRUCTURE ACTIVITY RELATION; SUICIDE; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY; VAGUS NERVE STIMULATION; VERBAL MEMORY;

ADULT; ANTICONVULSANTS; CHILD; COGNITION; COGNITION DISORDERS; COMORBIDITY; EPILEPSY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS;

EID: 84880153618     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000431382.06438.cd     Document Type: Review

References (84)

1. Witt JA, Helmstaedter C. Should cognition be screened in new-onset epilepsies? A study in 247 untreated patients. Journal of neurology 2012;259(8):1727-1731.
2. Loring DW, Meador KJ. Epilepsy: maximizing cognitive outcomes in epilepsy. Nat Rev Neurol 2012;8(8):416-417.
3. Smith DB, Craft BR, Collins J, et al. Behavioral characteristics of epilepsy patients compared with normal controls. Epilepsia 1986;27(6): 760-768. (Pubitemid 17226919)
4. Hermann B, Jones J, Sheth R, et al. Children with new-onset epilepsy: neuropsychological status and brain structure. Brain 2006; 129(pt 10):2609-2619. (Pubitemid 44522094)
5. Hermann BP, Seidenberg M, Dow C, et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol 2006;60(1):80-87.
6. Fuerst D, Shah J, Shah A, Watson C. Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study. Ann Neurol 2003;53(3):413-416. (Pubitemid 36258649)
7. Jokeit H, Ebner A. Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study. J Neurol Neurosurg Psychiatry 1999;67(1): 44-50. (Pubitemid 29278326)
8. Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003;54(4):425-432. (Pubitemid 37176535)
9. Meador KJ, Loring DW, Moore EE, et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995;45(8):1494-1499.
10. Prevey ML, Delaney RC, Cramer JA, et al. Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 1996;53(10):1008-1016.
11. Smith KR Jr, Goulding PM, Wilderman D, et al. Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch Neurol 1994;51(7):653-660. (Pubitemid 24201883)
12. Meador KJ, Loring DW, Hulihan JF, et al. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003;60(9):1483-1488. (Pubitemid 36554811)
13. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999;40(9):1279-1285. (Pubitemid 29416398)
14. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 2001;56(9):1177-1182. (Pubitemid 32405711)
15. Meador KJ, Loring DW, Vahle VJ, et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 2005;64(12): 2108-2114. (Pubitemid 40881003)
16. Salinsky MC, Storzbach D, Spencer DC, et al. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 2005;64(5):792-798. (Pubitemid 40316314)
17. Salinsky MC, Spencer DC, Oken BS, Storzbach D. Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav 2004;5(6):894-902. (Pubitemid 40003911)
18. Lee S, Sziklas V, Andermann F, et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003;44(3):339-347. (Pubitemid 36343764)
19. Park SP, Hwang YH, Lee HW, et al. Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients. Epilepsy Behav 2008;12(1):102-108.
20. Rowan AJ, Ramsay RE, Collins JF, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64(11): 1868-1873. (Pubitemid 40800699)
21. Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology 2004;62(6):872-877. (Pubitemid 38435770)
22. Meador KJ, Baker GA, Browning N, et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010;75(22):1954-1960.
23. Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360(16):1597-1605.
24. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013 Jan 22. [Epub ahead of print]
25. Vinten J, Bromley RL, Taylor J, et al. The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 2009;14(1):197-201.
26. Rasalam AD, Hailey H, Williams JH, et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005;47(8):551-555. (Pubitemid 41131614)
27. Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73(2):133-141. www.neurology.org/content/73/2/ 142.full.pdf.
28. Palac S, Meador KJ. Antiepileptic drugs and neurodevelopment: an update. Curr Neurol Neurosci Rep 2011;11(4):423-427.
29. Helmstaedter C, Reuber M, Elger CC. Interaction of cognitive aging and memory deficits related to epilepsy surgery. Ann Neurol 2003;52(1):89-94. (Pubitemid 34693748)
30. Helmstaedter C, Richter S, Roske S, et al. Differential effects of temporal pole resection with amygdalohippocampectomy versus selective amygdalohippocampectomy on material-specific memory in patients with mesial temporal lobe epilepsy. Epilepsia 2008;49(1):88-97.
31. Helmstaedter C. Neuropsychological aspects of epilepsy surgery. Epilepsy Behav 2004; 5 (suppl 1):S45-S55. (Pubitemid 38937082)
32. Helmstaedter C, Petzold I, Bien CG. The cognitive consequence of resecting nonlesional tissues in epilepsy surgeryV results from MRI- and histopathologynegative patients with temporal lobe epilepsy. Epilepsia 2011;52(8):1402-1408.
33. Dodrill CB, Morris GL. Effects of vagal nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav 2001;2(1): 46-53. (Pubitemid 33585770)
34. Morrell MJ; RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011;77(13): 1295-1304.
35. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010;51(5):899-908.
36. Wrench JM, Rayner G, Wilson SJ. Profiling the evolution of depression after epilepsy surgery. Epilepsia 2011;52(5):900-908.
37. Jacoby A, Baker GA, Steen N, et al. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996;37(2):148-161. (Pubitemid 26043793)
38. Gilliam F, Kuzniecky R, Faught E, et al. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997;38(2):233-236. (Pubitemid 27093337)
39. Marino SE, Meador KJ, Loring DW, et al. Subjective perception of cognition is related to mood and not performance. Epilepsy Behav 2009;14(3):459-464.
40. Hermann BP, Seidenberg M, Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000; 41(suppl 2):S31-S41. (Pubitemid 30387359)
41. Gilliam F, Kanner AM. Treatment of depressive disorders in epilepsy patients. Epilepsy Behav 2002;3(5S):2-9.
42. Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(suppl 10): S21-S47.
43. Kanner AM. Depression and epilepsy: a bidirectional relation? Epilepsia 2011; 52(suppl 1):21-27.
44. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001;11(2):240-249. (Pubitemid 32289413)
45. Wrench JM, Wilson SJ, Bladin PF, et al. Hippocampal volume and depression: insights from epilepsy surgery. J Neurol Neurosurg Psychiatry 2009;80(5):539-544.
46. Quiske A, Helmstaedter C, Lux S, et al. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 2000;39(2):121-125. (Pubitemid 30089584)
47. Schmitz EB, Moriarty J, Costa DC, et al. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy. J Neurol Neurosurg Psychiatry 1997;62(5):458-463. (Pubitemid 27237053)
48. Brody AL, Saxena S, Mandelkern MA, et al. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry 2001; 50(3):171-178. (Pubitemid 32763094)
49. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001;58(7):631-640. (Pubitemid 32640857)
50. Rayner G, Wilson SJ. Psychiatric care in epilepsy surgery: who needs it? Epilepsy Curr 2012;12(2):46-50.
51. Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011;52(11): 2133-2138.
52. Salinsky M, Evrard C, Storzbach D, et al. Psychiatric comorbidity in veteran with psychogenic seizures. Epilepsy Behav. 2012;25(3):345-349.
53. Turner K, Piazzini A, Chiesa V, et al. Patients with epilepsy and patients with psychogenic non-epileptic seizures: video-EEG, clinical and neuropsychological evaluation. Seizure 2011;20(9):706-710.
54. Kuyk J, Siffels MC, Bakvis P, et al. Psychological treatment of patients with psychogenic non-epileptic seizures: an outcome study. Seizure 2008;17(7):595-603.
55. Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004;110(4):207-220. (Pubitemid 39274055)
56. Pompili M, Girardi P, Tatarelli G, et al. Suicide after surgical treatment in patients with epilepsy: a meta-analytic investigation. Psychol Rep 2006;98(2):323-338. (Pubitemid 44186095)
57. Jones JE, Hermann BP, Barry JJ, et al. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003;4(suppl 3): S31-S38. (Pubitemid 37428235)
58. Hamid H, Devinsky O, Vickrey BG, et al. Suicide outcomes after resective epilepsy surgery. Epilepsy Behav 2011;20(3):462-464.
59. Hecimovic H, Santos JM, Carter J, et al. Depression but not seizure factors or quality of life predicts suicidality in epilepsy. Epilepsy Behav 2012;24(4):426-429.
60. Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia 2009;50(5): 978-986.
61. Blumer D. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harv Rev Psychiatry 2000;8(1):8-17. (Pubitemid 30246612)
62. Blumer D, Montouris G, Davies K. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav 2004;5(6):826-840. (Pubitemid 40003902)
63. Mula M, Jauch R, Cavanna A, et al. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia 2008;49(4):650-656. (Pubitemid 351661045)
64. Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 1997; 58(1):3-11. (Pubitemid 27089710)
65. Mula M, Jauch R, Cavanna A, et al. Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy. Epilepsia 2010;51(7):1139-1145.
66. Kanner AM, Barry JJ, Gilliam F, et al. Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy? Epilepsia 2010;51(7): 1152-1158.
67. Krahn LE, Rummans TA, Peterson GC, et al. Electroconvulsive therapy for depression after temporal lobectomy for epilepsy. Convuls Ther 1993;9(3):217-219. (Pubitemid 23284755)
68. Brandt C, Schoendienst M, Trentowska M, et al. Prevalence of anxiety disorders in patients with refractory focal epilepsyVa prospective clinic based survey. Epilepsy Behav 2010;17(2):259-263.
69. Kimiskidis VK, Triantafyllou NI, Kararizou E, et al. Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann Gen Psychiatry 2007;6:28.
70. Kanner AM, Trimble M, Schmitz B. Postictal affective episodes. Epilepsy Behav 2010; 19(2):156-158.
71. Kanner AM, Barry JJ, Gilliam F, et al. Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events? Epilepsia 2012;53(6): 1104-1108.
72. Adams SJ, O'Brien TJ, Lloyd J, et al. Neuropsychiatric morbidity in focal epilepsy. Br J Psychiatry 2008;192(6):464-469. (Pubitemid 351809901)
73. Kanner AM. Psychosis of epilepsy: a neurologist's perspective. Epilepsy Behav 2000;1(4):219-227.
74. Kanner AM, Ostrovskaya A. Long-term significance of postictal psychotic episodes I. Are they predictive of bilateral ictal foci? Epilepsy Behav 2008;12(1): 150-153. (Pubitemid 350246371)
75. Devinsky O, Abramson H, Alper K, et al. Postictal psychosis: a case control series of 20 patients and 150 controls. Epilepsy Res 1995;20(3):247-253.
76. Alper K, Devinsky O, Westbrook L, et al. Premorbid psychiatric risk factors for postictal psychosis. J Neuropsychiatry Clin Neurosci 2001;13(4):492-499. (Pubitemid 33140922)
77. Vickrey BG, Hays RD, Rausch R, et al. Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia 1994;35(3):597-607. (Pubitemid 24217763)
78. Spencer SS, Berg AT, Vickrey BG, et al. Health-related quality of life over time since resective epilepsy surgery. Ann Neurol 2007;62(4):327-334. (Pubitemid 350105947)
79. Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 2012;307(9):922-930.
80. Langfitt JT, Westerveld M, Hamberger MJ, et al. Worsening of quality of life after epilepsy surgery: effect of seizures and memory decline. Neurology 2007;68(23):1988-1994. (Pubitemid 46869702)
81. Perrine K, Hermann BP, Meador KJ, et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995;52(10):997-1003.
82. Lehrner J, Kalchmayr R, Serles W, et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999;8(2):88-92. (Pubitemid 29176753)
83. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(8 suppl 5): S9-S20.
84. Gilliam FG, Fessler AJ, Baker G, et al. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004;62(1): 23-27. (Pubitemid 38082864)